| contact us
 
 
Print PDF
 

FOUR JOIN BOARD OF SAFE-BIOPHARMA ASSOCIATION

Ft. Lee, N.J. (October 28, 2008) – GlaxoSmithKline (NYSE: GSK), Merck (NYSE:MRK), Pfizer (NYSE: PFE), and Procter & Gamble (NYSE: PG) have named new representatives to the Board of Directors of SAFE BioPharma Association, the non-profit association that created and manages the SAFE-BioPharma™ digital identity and signature standard for the pharmaceutical and healthcare industries.

“We welcome the new members of the board and look forward to their active participation in providing governance and major decision-making,” said Gary Secrest, Chairman, SAFE-BioPharma Association.

The new members of the board follow:
William Barnes, Director, Identity Services, Pfizer, Inc.
Richard Eddershaw, Director, Global Regulatory Informatics, Global Regulatory Operations, GlaxoSmithKline Pharmaceuticals.
Terence Rice, Senior Director, Information Security and Networks, Merck & Co. Inc.
Marilyn Teal, Pharm D., Director/Section Head, Clinical Operations, Procter & Gamble Pharmaceuticals.
Each new appointee replaces a representative from the respective member company.

###

About SAFE-BioPharma Association
SAFE-BioPharma Association is the non-profit association that created and manages the SAFE-BioPharma™ digital identity and signature standard for the pharmaceutical and healthcare industries. The SAFE-BioPharma industry standard is used to mitigate legal, regulatory and other business risk associated with business-to-business and business-to-regulator electronic transactions. It facilitates interoperability by providing a secure, enforceable, and regulatory-compliant way to verify identities of parties involved in electronic transactions. SAFE-BioPharma’s vision is to be a catalyst in transforming the biopharmaceutical and healthcare communities to a fully electronic business environment by 2012. The Association’s members include Amgen (NASDAQ: AMGN), AstraZeneca (NYSE: AZN), Bristol-Myers Squibb (NYSE:BMY), Genzyme (NASDAQ: GENZ), GlaxoSmithKline (NYSE: GSK), Johnson & Johnson (NYSE: JNJ), Merck (NYSE:MRK), Pfizer (NYSE: PFE), Procter & Gamble (NYSE: PG), Roche and Sanofi-Aventis (NYSE:SNY). For more information, visit  HYPERLINK "http://www.safe-biopharma.org" www.safe-biopharma.org.

SAFE-BioPharma™ is a trademark of SAFE-BioPharma Association. Any use of this trademark requires approval from
SAFE-BioPharma Association.